Ignacio Aznar Lou
Investigador post-doc
Researcher Ignacio Aznar Lou graduated in Pharmacy in 2014 from the Universidad San Jorge de Zaragoza and obtained his PhD in Pharmacy from the University of Barcelona in 2017.
In recent years he has carried out postdoctoral stays at Southern Denmark University (Denmark) and the University of Lisbon, where he studied various techniques for assessing population drug use and evidence review.
He is currently working on several projects related to the analysis of large real world databases in the fields of pharmacoepidemiology and pharmacoeconomics.
Professional network profiles
Last Publications
- Joan Domènech Abella, SANDRA DÍAZ COFINÉ, Rubio-Valera M and Aznar-Lou I Evaluación pre-post de un programa intergeneracional para mejorar el bienestar en personas mayores y los estereotipos edadistas en alumnos de primaria y secundaria: proyecto CRENCO. Revista Española De Geriatría Y Gerontología . 57(3): 161-167.
- Carbonell-Duacastella C, Rubio-Valera M, Marqués-Ercilla S, Peñarrubia-María MT, Maria Montserrat Gil Gribau, Garcia-Cardenas V, Pasarín MI, Parody-Rúa E and Aznar-Lou I Pediatric Medication Noninitiation in Spain. Pediatrics . 149(1): .
- Peñarrubia-María MT, Maria Montserrat Gil Gribau, Maria del Carmen Gallardo González, Aznar-Lou, Ignacio, Serrano-Blanco A, Mendive Arbeloa JM, Garcia-Cardenas, Victoria, Sanchez-Vinas, Alba and Rubio-Valera M Non-initiation of prescribed medication from a Spanish health professionals' perspective: A qualitative exploration based on Grounded Theory. HEALTH & SOCIAL CARE IN THE COMMUNITY . 30(1): .
Projects
- Project name:
- AR201903 - Eval. adherencia a antipsicóicos partir de datos
- Leader
- Ignacio Aznar Lou
- Funding entities:
- Parc Sanitari de Sant Joan de Déu -Serveis de Salut Mental
- Code
- AR201903
- Starting - finishing date:
- 2019 - 2021
- Project name:
- Ajuts de mobilitat universitària
- Leader
- Ignacio Aznar Lou
- Funding entities:
- Societat Econòmica Barcelonesa D'amics del Pais (SEBAP)
- Code
- Ajuts mobilitat SEBAP
- Starting - finishing date:
- 2017 - 2017
News
-
Dementia cases could triple by 2050 if countries do not address the risk factors
According to a study published in The Lancet Public Health, the number of people with dementia could triple by 2050. This study is conducted by an international research team with the participation of Dr. Ai Koyanagi and Dr. Jacob Louis of Epidemiology of Mental Disorders and Aging from IRSJD.